HSV-related Tracheobronchitis and Pneumonia in Critically Ill Patients
Author Information
Author(s): Ilka Engelmann, Jens Gottlieb, Astrid Meier, Dorit Sohr, Arjang Ruhparwar, Cornelia Henke-Gendo, Petra Gastmeier, Tobias Welte, Thomas Friedrich Schulz, Frauke Mattner
Primary Institution: Medizinische Hochschule Hannover
Hypothesis
What are the clinical relevance and risk factors for HSV-related tracheobronchitis or pneumonia in critically ill patients?
Conclusion
HSV-related tracheobronchitis or pneumonia is associated with increased mortality in critically ill patients.
Supporting Evidence
- Six out of eight patients with HSV detection had tracheobronchitis or pneumonia.
- Mortality was 100% in patients with HSV-related tracheobronchitis or pneumonia compared to 17.8% in those without.
- Identical HSV type 1 sequences were found in multiple patients, suggesting possible nosocomial transmission.
Takeaway
This study found that a virus called HSV can make very sick patients even sicker, and it can be very dangerous.
Methodology
A retrospective cohort study was performed to identify risk factors for HSV-related tracheobronchitis or pneumonia and death using univariable and logistic regression analysis.
Potential Biases
The analysis was initiated in a suspected outbreak situation, which may have influenced testing and diagnosis.
Limitations
The study had a small sample size and did not perform systematic testing for HSV in all patients.
Participant Demographics
The cohort included critically ill patients in a surgical intensive care unit, with a mix of underlying conditions.
Statistical Information
P-Value
<0.0001
Confidence Interval
2.72–1000
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website